Figure 3.

Effects of BMCs and BMRCs administration on neurological function (Modified Neurological Severity Score) in rats with cerebral ischemia at 24 hours, 7 and 14 days after transplantation.
aP < 0.05, vs. control group at the same time; bP < 0.05, vs. BMCs group at the same time point. Data were expressed as mean ± SD of six rats for each group at each time point (one-way analysis of variance and least significant difference t-test). Higher scores indicates more severe neurological function deficit.
BMCs: Bone marrow cells; BMRCs: bone marrow regenerative cells.